Name: Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye (Video) | JoVE Journal
Uploaded: 2012-11-25T14:00:00.000+00:00
Duration: 5 min 9 s
Description: Learn subretinal injection of gene therapy vectors and stem cells in perinatal mouse eyes using a custom glass capillary device. This technique enables precise delivery for retinal disease research.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

Research to Prevent Blindness; Experimental assistance from Takayuki Nagasaki; This research complies with the ARVO Statement for the Use of Animals in Ophthalmic and Visual Research. KJW is supported by NIH grants 5T32EY013933 and 5T32DK007647-20. VBM is supported by NIH grant K08EY020530.

1. Assemble Devices for the Subretinal Injection
<ol>
 <li>Purchase or make a 100 &mu;m diameter needle from a glass capillary tube. This can be done manually by using a Sutter P-97 pipet puller or other similar equipment. The end of the capillary tube will be heated and pulled until it reaches the desired diameter (100 &mu;m). A smaller diameter needle can be used for gene therapy vectors; however, this is the recommended diameter for cell injection without damage to the cells or the eye. Compared to steel needles, the glass capillary needle has a very fine, but blunt tip, to allow for visualization of the injection fluid and access to the subretinal space without causing retinal breakage. Clean these pulled needles if needed using 70% ethanol, and store in a sterile container. A 15 cm sterile tissue culture dish with tape to hold the needles in place is one way in which to keep the injection needles covered and in a sterile environment. At this point, complete the set-up within the surgical room where the procedure will take place. It is easiest to keep all equipment in the surgical room at all times in order for it to remain sterile, especially if this procedure is done within a barrier facility.</li>
 <li>Aspirate silicone into the injection needle and eject the silicone to leave a coating along the inner walls of the needle. The silicone coating maximizes the passage of cells and viruses through the needle bore, which would otherwise stick to the inner glass capillary walls.</li>
 <li>Obtain an approximately 8 cm length of sterile plastic tubing by cutting a 25 &frac34;-gauge blood collection set with luer-lock at the point directly after the needle (removing the needle from the tubing).</li>
 <li>Fill a 1 ml Sub-Q 26 5/8-gauge slip-tip syringe with sterile saline and remove the needle from the syringe. </li>
 <li>Attach the injection needle to the cut end of the plastic tubing and attach the syringe to the luer-lock at the other end. </li>
 <li>Aspirate sterile saline to fill the dead space in the tubing and capillary needle, ejecting some saline through the needle to ensure that it is correctly attached without any leakage. Next, aspirate a small, approximately 1 &mu;l amount of air, into the tip of the injection needle. This will separate the saline from the injection fluid and provide a visual cue indicating the end of the injection fluid during the surgical procedure. The injection apparatus should be kept on a clean surface wiped down with 70% ethanol during the surgical procedure. Additionally, all equipment used during the surgical procedure should be cleaned both before and after with 70% ethanol, for the exception of the injection needles which should already be kept sterile and ready for use. These needles should be disposed of after surgery, and not re-used.</li>
 <li>Finally, aspirate injection solution containing the desired packaged gene therapy viral vector or stem cells. This can be done by taking up the injection solution into a sterile pipet tip, then pipetting the solution onto the surface of a sterile cell culture dish. The solution can now be easily aspirated into the injection needle using the syringe. The amount needed will vary depending on the age of the mouse. For our purposes we use post-natal day 5 mice, which can be injected with 0.5-0.8 &mu;l of injection fluid. Smaller amounts, 0.5 &mu;l or less, can be used for younger mice and larger amounts, such as 1 &mu;l, can be used for adult mice. The viral titer or number of cells needs to be determined based on the virus/cells being injected and their desired target tissue, as too many viral particles or cells in a small volume can lead to toxicity for the retinal cells. In the video, for visualization purposes, we have used 1.5 &mu;l, a greater amount of dye than necessary to inject into the eye. </li>
</ol>
2. Accessing the Subretinal Space
<ol>
 <li>Within the sterile surgical room, stabilize or anesthetize the mouse according to the locally approved animal handling protocol, which will vary by age of the mouse. Common anesthesia for adult mice includes the use of isoflurane gas or an intra-peritoneal injection of 0.1 ml/10g body weight of ketamine (100 mg/ml) and xylazine (20 mg/ml) in sterile saline. For perinatal mice, common anesthesia techniques include the use of isoflurane gas or cryoanesthesia (hypothermia). All anesthesia techniques must be approved by your local IACUC committee before use. We typically use post-natal day (P) 5 mice, although similar techniques can be applied to mice as young as P0 or to adult mice. The surgical procedure cannot begin until the mouse has ceased moving the limbs and no longer responds to toe pinches. For perinatal mice, they will become noticeably lighter in color since the blood flow will slow down, another key to knowing that they are fully under anesthesia.</li>
 <li>In perinatal mice, use Vannas straight scissors to make an approximate 1.5 mm incision along the closed lid fissure. Be careful to cut at the indentation, where the eye will naturally open in the future. This ensures that the lids will heal and open properly during the development of the mouse. A surgical blade can be used for this purpose, although we prefer Vannas scissors since they reduce the risk of puncturing the eye during this procedure. In the video, the scissors were used to directly puncture and cut along the eyelid margin. When learning this technique, forceps should be used to lift the eyelid before cutting and reduce the risk of damaging the eye.</li>
 <li>Pull apart the eyelids with curved dressing forceps to proptose the eye and pinch the eyelids slightly underneath the eye to hold it proptosed for injection. If the lid incision made in step two is too large, the eye will slip back under the lids and prevent adequate exposure during the injection procedure. For adult mice, applying slight pressure around the eye with dressing forceps can hold the eye proptosed for injection.</li>
 <li>Make a small scleral incision at or posterior to the globe's equator by scratching the surface with a 15-degree microsurgery blade. This incision should be only large enough to pass the tip of the injection needle, but no larger than that. If preferred, a small, sharp needle such as an acupuncture needle can be used to make this incision into the subretinal space instead of the microsurgery blade. In darkly pigmented animals, a dark brown-pigmented tissue (the choroid-retinal pigment epithelium) will become visible at the point of incision. In lighter pigmented or albino mice, a surgical marking pen can be applied to the tip of the microsurgery blade to leave an ink spot indicating the incision site. If clear (vitreous) fluid refluxes from the incision site, the blade was placed too deep and entered the vitreous cavity and the therapeutic virus or cells may enter the intravitreal space during injection. For visualization purposes, we have made the incision to this point in the video. It is still possible to complete a subretinal injection in this case, however the retinal detachment caused by the presence of the injection fluid may not fully heal in this mouse. Therefore, care must be taken to cut only the outer surface of the eye and not through the retina before injection. </li>
 <li>Carefully insert the injection needle into the incision site and advance it parallel to the outer eye wall to enter the subretinal space. Advancing too close to the outer wall or too deep within the eye will direct the injection into the wrong location. The best method to understand whether the needle is in the correct location is to practice the technique. Practicing on lightly pigmented or albino mice can help to make precise and accurate injections into the subretinal space. This is because the needle and injection fluid is visible within these eyes.</li>
 <li>Apply light pressure to the syringe plunger and begin injection of the desired fluid. If the needle is correctly placed within the subretinal space, moderate backpressure will be felt. If the needle is within the vitreous, there will be significantly less backpressure and potentially some fluid reflux during the injection. If there is significant backpressure, hold the needle in place for at least an additional 15 seconds before removing the needle slowly. This will allow the high intraocular pressure to equalize instead of refluxing the injected virus or cells back out the incision site. Some of the air and saline may be injected into the subretinal space due to the increased pressure required during the injection procedure. Care should be taken not to over-inject air or saline, since it can flush out the injected virus or cells from the eye. It is also possible to cause permanent retinal detachment from the presence of too much fluid injected into the subretinal space. For visualization purposes, excess dye and air was injected into the subretinal space in the video. It can be clearly seen how some of the dye will be flushed back out of the subretinal space if too much is injected, but also how the air bubble remains within the subretinal space and does not disappear into the vitreous. This was used to emphasize that these injections were all within the correct location of the eye, so one can visualize how the needle should enter the incision site. All injections into the subretinal space cause a temporary retinal detachment due to the presence of the injection fluid. If the injection procedure is completed correctly, this temporary retinal detachment will heal within 24 hr and mice can be used for all further experiments. The eye may remain soft for approximately one week due to the surgical procedure, so a second injection should be avoided during this period of time.</li>
 <li>For neonatal mice, use the curved dressing forceps to gently push the eye back behind the lids and into the orbit. It may be useful to wait for a minute in order to allow the virus to settle within the subretinal space and not cause it to be flushed out of the incision site when gently pushing the eye back into its orbit. After surgery, one drop of 0.5% bupivacaine (marcaine) diluted to 0.25% in sterile saline from a 25-gauge needle can be placed at the injection site. Mice do not show overt signs of distress after subretinal surgery and the use of bupivacaine as a long-acting topical analgesic has been ample for the previous three years. Mice should always be monitored after the surgical procedure to look for any signs of distress; such as infection, swelling, or a decrease in the usual daily activities of the mouse. If these occur, the veterinarian should be notified and further pain medications such as buprenorphine (0.05 mg/kg) can be given as an intraperitoneal injection.</li>
 <li> Wake the mouse from anesthesia according to locally approved animal handling protocol. The mouse should be kept on a heating pad to maintain normal body temperature as it wakes from the anesthetic. The surgical procedure should take less than five minutes to complete, not counting the time for the mouse to undergo anesthesia. Therefore, a heating pad is not necessary during the actual procedure, but may be needed while one is learning the technique as the procedure could take a longer duration of time. The mouse should not be placed back into a clean cage until it has begun to move around on its own. For neonates, gentle toe pinches will help for them to fully recover from the anesthesia, and they should regain their pink color and movement before being placed back with the mother. Mice should be monitored over time for any signs of distress as listed previously.</li>
</ol>

<ol><li>Prevalence of Blindness Data Tables [NEI Statistics and Data]. , National Eye Insitute. Available from: 
		
 <a target="_blank" href="http://www.nei.nih.gov/eyedata/pbd_tables.asp">http://www.nei.nih.gov/eyedata/pbd_tables.asp</a> (2011).</li>
<li>Abe, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Regeneration+of+the+retina+using+pigment+epithelial+cell+transplantation%5BTitle%5D)+AND+%22Nihon+Ganka+Gakkai+Zasshi%22%5BJournal%5D)">Regeneration of the retina using pigment epithelial cell transplantation.</a> Nihon Ganka Gakkai Zasshi. 106, 778-803 (2002).</li>
<li>Jacobson, S. G., Cideciyan, A. V., Ratnakaram, R., Heon, E., Schwartz, S. B., Roman, A. J., Peden, M. C., Aleman, T. S., Boye, S. L., Sumaroka, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Gene+therapy+for+Leber+congenital+amaurosis+caused+by+RPE65+mutations%3A+safety+and+efficacy+in+15+children+and+adults+followed+up+to+3+years%5BTitle%5D)+AND+%22Arch.+Ophthalmol%22%5BJournal%5D)">Gene therapy for Leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years.</a> Arch. Ophthalmol. 130, 9-24 (2011).</li>
<li>Schwartz, S. D., Hubschman, J. P., Heilwell, G., Franco-Cardenas, V., Pan, C. K., Ostrick, R. M., Mickunas, E., Gay, R., Klimanskaya, I., Lanza, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Embryonic+stem+cell+trials+for+macular+degeneration%3A+a+preliminary+report%5BTitle%5D)+AND+%22Lancet%22%5BJournal%5D)">Embryonic stem cell trials for macular degeneration: a preliminary report.</a> Lancet. 379, 713-720 (2012).</li>
<li>Wang, N. K., Tosi, J., Kasanuki, J. M., Chou, C. L., Kong, J., Parmalee, N., Wert, K. J., Allikmets, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Transplantation+of+reprogrammed+embryonic+stem+cells+improves+visual+function+in+a+mouse+model+for+retinitis+pigmentosa%5BTitle%5D)+AND+%22Transplantation%22%5BJournal%5D)">Transplantation of reprogrammed embryonic stem cells improves visual function in a mouse model for retinitis pigmentosa.</a> Transplantation. 89, 911-919 (2010).</li>
<li>Song, B. J., Tsang, S. H., Lin, C. -S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Genetic+models+of+retinal+degeneration+and+targets+for+gene+therapy%5BTitle%5D)+AND+%22Gene+Ther.+Mol.+Biol%22%5BJournal%5D)">Genetic models of retinal degeneration and targets for gene therapy.</a> Gene Ther. Mol. Biol. 11, 229-262 (2007).</li>
<li>Tosi, J., Sancho-Pelluz, J., Davis, R. J., Hsu, C. W., Wolpert, K. V., Sengillo, J. D., Lin, C. S., Tsang, S. H. Lentivirus-mediated expression of cDNA and shRNA slows degeneration in retinitis pigmentosa. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aTosi%2C+J+%22Exp.+Biol.+Med%22">Exp. Biol. Med</a>. 236, 1211-1217 (2011).</li>
<li>Tucker, B. A., Park, I. H., Qi, S. D., Klassen, H. J., Jiang, C., Yao, J., Redenti, S., Daley, G. Q., Young, M. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Transplantation+of+adult+mouse+iPS+cell-derived+photoreceptor+precursors+restores+retinal+structure+and+function+in+degenerative+mice%5BTitle%5D)+AND+%22PLoS+One%22%5BJournal%5D)">Transplantation of adult mouse iPS cell-derived photoreceptor precursors restores retinal structure and function in degenerative mice.</a> PLoS One. 6, e189992(2011).</li>
<li>Mahajan, V. B., Mondino, B. J., Tsang, S. H. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aMahajan%2C+VB+%22A+high-throughput+Mouse+Eye+Phenomics+System%22">A high-throughput Mouse Eye Phenomics System</a>. , Cold Spring Harbor Laboratories. (2010).</li>
<li>Chang, B., Hawes, N. L., Hurd, R. E., Davisson, M. T., Nusinowitz, S., Heckenlively, J. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Retinal+degeneration+mutants+in+the+mouse%5BTitle%5D)+AND+%22Vision+Res%22%5BJournal%5D)">Retinal degeneration mutants in the mouse.</a> Vision Res. 42, 517-525 (2002).</li>
<li>Hawes, N. L., Smith, R. S., Chang, B., Davisson, M., Heckenlively, J. R., John, S. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mouse+fundus+photography+and+angiography%3A+a+catalogue+of+normal+and+mutant+phenotypes%5BTitle%5D)+AND+%22Mol.+Vis%22%5BJournal%5D)">Mouse fundus photography and angiography: a catalogue of normal and mutant phenotypes.</a> Mol. Vis. 5, 22(1999).</li>
<li>Won, J., Shi, L. Y., Hicks, W., Wang, J., Hurd, R., Naggert, J. K., Chang, B., Nishina, P. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mouse+model+resources+for+vision+research%5BTitle%5D)+AND+%22J.+Ophthalmol%22%5BJournal%5D)">Mouse model resources for vision research.</a> J. Ophthalmol. 2011, 391384(2011).</li>
</ol>

No conflicts of interest declared.

This video technique provides instructions on completing the subretinal injection surgical procedure successfully, and ensuring that the gene therapy vector or stem cells are placed in the location necessary to efficiently treat the ophthalmic disease. This technique allows for the targeting of retinal cells such as the RPE or photoreceptors, since it places the gene therapy vectors or stem cell-derived tissues in the vicinity of these cells. Previous methods involved intravitreal injections, where the fluid is placed wi...

<table><tbody><tr><td>0.8-1.10 x 100 mm Capillary Tube (glass)</td><td>Kimble Glass, Inc.</td><td>34502 99</td><td></td></tr><tr><td>Flaming/Brown Micropipette Puller </td><td>Sutter Instrument</td><td>P-97</td><td>Narishige microforge can be used instead. Catalog #MF-900 </td></tr><tr><td>Sigmacote</td><td>Sigma Aldrich</td><td>SL2-25ML</td><td>Silicone</td></tr><tr><td>Dubecco&#039;s Phosphate Buffered Saline with Calcium Chloride and Magnesium Chloride</td><td>Gibco-Invitrogen</td><td>14040-133</td><td></td></tr><tr><td>Safety-Lok 25 3/4G x 12&quot;; Blood Collection Set</td><td>B-D Vacutainer</td><td>367298</td><td></td></tr><tr><td>1 ml Sub-Q 26 5/8G Slip-Tip Syringe</td><td>Becton-Dickinson</td><td>309597</td><td></td></tr><tr><td>0.5-10 &amp;mu;l Finnpipette II Adjustable-Volume Pipetter</td><td>Fisherbrand</td><td>21-377-815</td><td></td></tr><tr><td>1-200 &amp;mu;l Natural Beveled Tips</td><td>USA Scientific, Inc.</td><td>1111-1700</td><td></td></tr><tr><td>Discovery.V8 Stereo Microscope</td><td>Zeiss</td><td>MC1500</td><td></td></tr><tr><td>60 mm x 15 mm Style Treated Polystyrene Cell Culture Dish</td><td>Corning Incorporated</td><td>430166</td><td></td></tr><tr><td>Vannas Straight Scissors</td><td>Storz Ophthalmics</td><td>E3383 S</td><td></td></tr><tr><td>Curved Dressing Forceps with Serrations Delicate</td><td>Storz Ophthalmics</td><td>E1408</td><td></td></tr><tr><td>15 Degree Microsurgery Knife</td><td>Wilson Ophthalmic Corp.</td><td>091204</td><td></td></tr><tr><td>Ketamine</td><td>Ketaset III</td><td>NADA #45-290</td><td></td></tr><tr><td>Xylazine</td><td>Lloyd Laboratories</td><td>NADA #139-236</td><td></td></tr><tr><td>Bupivacaine (Marcaine)</td><td>AstraZeneca</td><td>N/A</td><td></td></tr><tr><td>Buprenorphine </td><td>Sigma Aldrich</td><td>B9275</td><td></td></tr></tbody></table>

subretinal injection of gene therapy vectors and stem cells in the perinatal mouse eye

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

The loss of sight affects approximately 3.4 million people in the United States and is expected to increase in the upcoming years.1 Recently, gene therapy and stem cell transplantations have become key therapeutic tools for treating blindness resulting from retinal degenerative diseases. Several forms of autologous transplantation for age-related macular degeneration (AMD), such as iris pigment epithelial cell transplantation, have generated encouraging results, and human clinical trials have begun for other forms of gene and stem cell therapies.2 These include RPE65 gene replacement therapy in patients with Leber's congenital amaurosis and an RPE cell transplantation using human embryonic stem (ES) cells in Stargardt's disease.3-4 Now that there are gene therapy vectors and stem cells available for treating patients with retinal diseases, it is important to verify these potential therapies in animal models before applying them in human studies. The mouse has become an important scientific model for testing the therapeutic efficacy of gene therapy vectors and stem cell transplantation in the eye.5-8 In this video article, we present a technique to inject gene therapy vectors or stem cells into the subretinal space of the mouse eye while minimizing damage to the surrounding tissue.

A drawing of the mouse eye is shown with major structures labeled for reference, with arrows displaying the locations for both intravitreal and subretinal injection surgical procedures (arrowheads, Figure 1). Gene therapy vectors, such as the lacZ lentiviral vector (Figure 2), can be injected using these locations. Additionally, stem cells, such as mouse embryonic stem cells (Figure 3), can also be transplanted at these sites in the mouse eye. 
<p class="jov...

This surgical technique illustrates the injection of gene therapy vectors and stem cells into the subretinal space of the mouse eye.

The loss of sight affects approximately 3.4 million people in the United States and is expected to increase in the upcoming years.1 Recently, gene therapy ...

The first step is to assemble the device from a blood collection set. Cut a 25 and threequarter gauge needle from this eight centimeter length of sterile tubing. With a lure lock, you can purchase a hundred micron diameter glass capillary needle, or make one yourself with a Sutter P 97 pipette Puller, then aspirate sterile saline to fill the dead space in the tubing.Attach a glass capillary tube to the end of the sterile plastic tubing, eject some saline through the needle to ensure that it is correctly attached without any leakage. If you look under a microscope, see how much pressure is applied and the rate of fluid ejection through the fine tip, we'll use a colored solution to represent the viral vector or stem cells. Place this in a sterile Petri dish, aspirate some air, and then the injection solution.For our purposes, we use P five mice. In this image, you can see the snout. The location of the eye is covered by an eyelid.The dotted lines show the lid margin and the lid crease where the incision will be made. Vanis, straight scissors are used to make a one and a half millimeter incision along the closed lid. Fissure pressing forceps are used to pull apart the eyelids and pop to the eye with the lid margin slightly behind the eyeball.To make the sclerotomy, it's important to be able to identify a few landmarks. The transition from the clear cornea to the sclera is marked by the limbus. Just inside the sclera is the retinal pigment epithelium, then the retina, and then the vitreous Matomy is placed halfway back or at the equator of the globe incision by scratching the surface with a 15 degree microsurgical blade and darkly pigmented animals.A dark brown pigmented tissue will become visible at the point of incision. If the incision is made too far, you'll actually see fluid come out. This represents the vitreous and it means that you've gone too far.Passing the RPE retina. This incision could be used for an intravitreal injection. Now, BYO animal.The incision at this point is complete Additional incision and scratches will release vitreous for a subretinal injection, the goal is to place the micro capillary glass tube into the subretinal space, just between the retina and the RPE. If the incision was too deep, then the needle can be passed past the retina into the vitreous. Insert the needle parallel to the outer wall eye.To enter a subretinal space. Apply light pressure to the plunger and begin injecting the fluid. If the needle is correctly placed, moderate back pressure will be felt, and a BLE will be created in the subretinal space.If the needle is in the vitreous, there is significantly less back pressure. To avoid significant reflux, hold a plunger in place for an additional 15 seconds before removing the needle. This will allow the interocular pressure to stabilize.Gently push the eye back behind the lids into the orbit using curved dressing forceps. Here's another example of a subretinal injection where the dye fills the subretinal space and is clearly visible in an albino animal. The air meniscus allows you to see when you reach the end of your injection.Fluid injections in a darkly pigmented eye are a little bit more challenging. The careful insertion of the needle will achieve excellent results.

subretinal-injection-gene-therapy-vectors-stem-cells-perinatal-mouse

Research

JoVE Journal

Medicine

Here we present two techniques for manipulating gene expression in murine retinal ganglion cells (RGCs) by in utero and ex vivo electroporation.  These techniques enable one to examine how alterations in gene expression affect RGC development, axon guidance, and functional properties.

In utero and ex vivo Electroporation for Gene Expression in Mouse Retinal Ganglion Cells

A method for the incorporation of plasmid DNA into murine retinal cells for the purpose of performing either gain- or loss of function studies in vivo is presented.  This method capitalizes on the transient increase in permeability of cell plasma membranes induced by the application of an external electrical field.

In vivo Electroporation of Developing Mouse Retina

Source: Park, S. W., et al. Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium. J. Vis. Exp. (2015)The video describes the method for subretinal injection of viral vectors into the retinal pigment epithelium (RPE) in a mouse model. It details the procedure from anesthesia and eye preparation to precise lentiviral vector delivery, ensuring gene integration and expression in the RPE.

Subretinal Injection of Viral Vectors into the Retinal Pigment Epithelium in a Mouse Model

Here we present a community accepted protocol in multimedia format for subretinally injecting a bolus of RPE cells in rats and mice. This approach can be used for determining rescue potentials, safety profiles, and survival capacities of grafted RPE cells upon implantation in animal models of retinal degeneration.

Performing Subretinal Injections in Rodents to Deliver Retinal Pigment Epithelium Cells in Suspension

Subretinal injection is a surgical technique for effective gene delivery to retinal pigment epithelium in the mouse eye.  Here we describe an easy and replicable method for subretinal injection of viral vectors to retinal pigment epithelium in experimental mice.

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Subretinal injections are the most common technique for delivering large therapeutic agents such as proteins and viral vectors to photoreceptors and the retinal pigment epithelium. An alternative method in mice that successfully targets the subretinal space with minimal collateral damage and fast recovery times is described here.

An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach

Here we demonstrate a novel approach to using high resolution spectral-domain optical coherence tomography (HR-SD-OCT) to assist delivery of gene therapy agents into the subretinal space, assess its areal coverage, and characterize photoreceptor vitality.

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

This protocol presents a transpupillary vision-guided trans-scleral approach to safely and precisely deliver subretinal cellular grafts, with a low rate of surgical complications, in mouse recipients with or without retinal degeneration.

Transpupillary-Guided Trans-Scleral Transplantation of Subretinal Grafts in a Retinal Degeneration Mouse Model

We describe a detailed protocol for the preparation of post-cryopreserved hESC-derived photoreceptor progenitor cells and the sub-retinal delivery of these cells in rd10 mice.

Sub-Retinal Delivery of Human Embryonic Stem Cell Derived Photoreceptor Progenitors in rd10 Mice

This article provides a protocol and an accompanying video for the retrobulbar sinus injection of up to a total volume of 150 µL for postnatal, juvenile, and runted adult mice. This procedure is particularly well suited for the injection of small mice (15 g) when tail vein injection is not feasible.

Systemic Treatment for Postnatal, Juvenile, and Runted Adult Mice by Retrobulbar Sinus Injection

Subretinal injections are an indispensable technique for preclinical development of therapeutics for photoreceptor and RPE diseases. We describe an optimized transscleral subretinal injection technique in mice that improves intraoperative success rates and minimizes retinal damage.

Optimized Minimally Invasive Transscleral Subretinal Injection Technique in Mouse

Learn subretinal injection of gene therapy vectors and stem cells in perinatal mouse eyes using a custom glass capillary device. This technique enables precise delivery for retinal disease research.

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Explore More Videos